Angiosarcoma is a rare cancer of cells that line blood or lymph vessels. In an arm or leg it may involve skin or deeper soft tissues. A persistent, enlarging or bleeding skin change, or a growing deep lump, deserves assessment, although many such changes have other causes. Tissue tests establish the diagnosis. Treatment then considers the whole area involved, any spread elsewhere and what the proposed treatment would mean for a useful limb.[1][3][6]
On this page
What changes need examination?
Skin angiosarcoma may appear purple and develop several separate spots. A deeper tumour may present as an enlarging lump. Colour does not identify the diagnosis: benign blood-vessel abnormalities and other skin or soft-tissue conditions can look similar.[1][3]
Long-standing lymphoedema, swelling caused by impaired lymph drainage, and previous radiotherapy are recognised risk settings. Angiosarcoma can also occur without a known cause. These details help the clinician assess a new change; they do not establish why one person developed cancer.[1][4]
Arrange an assessment for an unexplained change that persists, grows or repeatedly bleeds, including on a chronically swollen limb. A photograph may help show change over time, but it cannot replace examination or a tissue diagnosis. A suspicious area should be assessed before arranging its removal.[1][3]
How is the diagnosis confirmed?
A biopsy provides tissue for a specialist pathologist to examine. Laboratory stains look for proteins that help identify the cell type. They are interpreted together with the tissue appearance and clinical findings, because vascular-looking lesions are not all the same disease.[1][4]
The sampling method depends on the site. A small punch biopsy may suit a skin lesion; a deeper mass usually needs a planned needle biopsy guided by imaging. The biopsy plan should fit the later tumour-removal operation. A small surface procedure is not automatically the right way to sample a deep lump.[1][3]
Why assess beyond the visible edge?
MRI helps map deep disease and its relationship to muscles, nerves and major blood vessels. Skin involvement can extend beyond what MRI shows, so examination, photographs and selected additional skin samples may help establish its extent. Staging scans also check for disease elsewhere, including the lungs and other sites relevant to angiosarcoma.[1]
Location and local extent matter
Swipe across the illustration to see all labels.
One deep mass and several skin foci create different planning problems. Treatment must cover the area that is actually involved, rather than remove only the most obvious spot. This guide concerns skin and soft-tissue disease; a tumour starting within bone needs its own bone-sarcoma and reconstruction assessment.[1]
When is surgery the main treatment?
For localised disease, meaning cancer confined to its original area, surgery may aim at complete removal with a surrounding margin. A negative margin means cancer is not seen at the examined cut edge. The team assesses whether that clearance is feasible and what removing nearby tissue would mean for the limb.[1][3]
If a deep tumour involves a major blood vessel, removing and reconstructing the vessel may be part of the operation. Skin coverage may also need reconstructive surgery. The expected result should be explained in everyday terms: walking, hand use, wound care, swelling and the activities that matter to the person.[1][3]
Extensive skin disease or several tumour foci can make clearance difficult. That calls for a discussion of the available combinations of treatment and their burden. Amputation may be considered in selected cases, but it should not be assumed from the diagnosis alone.[3][4]
What can radiotherapy and medicines add?
Radiotherapy treats the tumour area to improve local control. It is often considered alongside surgery, though selected limited tumours may not need it. Timing depends on the planned operation, previous radiation and wound healing. Radiation before and after surgery involve different trade-offs, including wound problems and later stiffness or swelling.[1][3]
More about the evidence
Angiosarcoma-specific prospective evidence for radiation around surgery is limited. The 2024 Italian consensus distinguishes anatomical settings; the 2025 Japanese cutaneous guideline also describes substantial uncertainty for lymphoedema-associated limb disease. These are reasons for a site-specific decision, rather than automatically applying a scalp or breast treatment plan to a thigh tumour.[1][4]
Medicines may be used when cancer has spread (metastatic disease) or cannot be adequately removed (unresectable disease). They may also be considered before an operation in selected cases. The goal might be to reduce tumour burden, relieve symptoms or control growth. The oncologist weighs that purpose against the treatment’s risks and the person’s health.[1][3]
Paclitaxel is one medicine with activity in advanced angiosarcoma. It can cause tiredness, low blood counts and serious complications. Evidence of benefit in advanced disease does not mean everyone should receive it after complete removal of a limb tumour.[1][2]
More about the evidence
ANGIOTAX was a nonrandomised phase II study of 30 people with metastatic or unresectable angiosarcoma at different sites. It reported anticancer activity and serious toxicity, including one treatment-related death. It did not test routine postoperative treatment after complete removal of localised limb angiosarcoma.[2]
What does recovery and follow-up involve?
Recovery depends on the tissues removed, reconstruction and any radiation or medicines. Rehabilitation addresses safe movement and useful function while respecting wound and tissue healing. Persisting swelling, weakness or stiffness may need ongoing care. Keeping a limb and regaining its previous strength are different outcomes.[3]
Follow-up assesses the treated area, possible spread and treatment effects. New skin spots, a recurrent lump or a sustained change in symptoms should be reported between visits. The follow-up plan should match the tumour’s extent and treatment. Because skin, deep-tissue and bone angiosarcomas differ, a single pooled survival figure would be misleading here.[1][3]
Seek emergency help for heavy bleeding
Substantial active bleeding needs immediate medical help, particularly if it will not stop or the person feels faint or becomes unwell. Apply firm direct pressure with a clean dressing or cloth while help is being arranged. Do not wait for a routine cancer appointment.[5]
